Sanchez Crespo M, Inarrea P, Nieto M L, Fernandez-Gallardo S
Pharmacol Res Commun. 1986 Aug;18 Suppl:181-96. doi: 10.1016/0031-6989(86)90051-2.
The pathophysiology of the shock state includes a variety of hemodynamic changes such as systemic hypotension, pulmonary hypertension and increased vascular permeability leading to the extravasation of protein rich plasma. These changes can be initiated by different etiological factors, but many of them have been related to the stimulation of activation systems (complement, kinins, etc.) or to the generation of inflammatory mediators. The purpose of the present study has been to obtain evidence of the involvement of paf-acether in the pathogenesis of the shock state initiated in rat and mouse by Gram-negative bacteria and soluble aggregates of immunoglobulin G. The injection of 1-2 MDa aggregates of immunoglobulin G to normal Sprague-Dawley rats, induced a dose-dependent systemic hypotension which appeared about five minutes after completion of the intravenous challenge. Simultaneously, extravasation of protein-rich plasma occurred as judged from the finding of an increased clearance of 125I-BSA. In similar experiments in mice, a reduction of the vascular volume was observed using 51Cr-labelled homologous red blood cells. Under these conditions, a lipid compound analogous to paf-acether was obtained from the liver and the spleen of these animals. The generation of this compound preceded the development of blood volume depletion and could be suppressed by either quinacrine or depletion of mononuclear phagocytes by total irradiation with 700 rads. The previous treatment of the rats with the compound BN 52021 (a specific antagonist of the paf-acether receptor) at a dose of 5mg/kg, i.v., prevented the appearance of hypotension and extravasation in response to an i.v. challenge with soluble aggregates of immunoglobulin G. Interestingly, the reversal of hypotension was also observed when BN 52021 was infused after the immunoaggregates (5mg/kg). The possible involvement of paf-acether in the hemodynamic changes of Gram-negative sepsis was studied in rats which had received an intraperitoneal inoculation of E. coli. The animals inoculated with the doses of bacteria which produced mortality showed a time- and dose-dependent increase of vascular permeability as judged from the presence of abundant peritoneal exudate and the reduction of the circulating volume. Simultaneously, significant amounts of paf-acether could be obtained from the peritoneal exudate and from the spleen preceding to the development of the circulating volume depletion.(ABSTRACT TRUNCATED AT 400 WORDS)
休克状态的病理生理学包括多种血流动力学变化,如全身低血压、肺动脉高压和血管通透性增加,导致富含蛋白质的血浆外渗。这些变化可由不同的病因引发,但其中许多与激活系统(补体、激肽等)的刺激或炎症介质的产生有关。本研究的目的是获取证据,证明血小板活化因子(PAF)在革兰氏阴性菌和免疫球蛋白G可溶性聚集体引发的大鼠和小鼠休克状态发病机制中的作用。给正常的斯普拉格-道利大鼠注射1-2兆道尔顿的免疫球蛋白G聚集体,会诱导剂量依赖性的全身低血压,在静脉注射挑战完成后约五分钟出现。同时,从125I-牛血清白蛋白清除率增加的结果判断,富含蛋白质的血浆发生了外渗。在小鼠的类似实验中,使用51Cr标记的同源红细胞观察到血管容量减少。在这些条件下,从这些动物的肝脏和脾脏中获得了一种类似于血小板活化因子的脂质化合物。这种化合物的产生先于血容量减少的发展,并且可以被奎纳克林或用700拉德的全照射耗尽单核吞噬细胞所抑制。以5毫克/千克的剂量静脉注射化合物BN 52021(血小板活化因子受体的特异性拮抗剂)对大鼠进行预处理,可防止在静脉注射免疫球蛋白G可溶性聚集体后出现低血压和外渗。有趣的是,在免疫聚集体(5毫克/千克)后输注BN 52021时,也观察到了低血压的逆转。在接受腹腔接种大肠杆菌的大鼠中,研究了血小板活化因子在革兰氏阴性菌败血症血流动力学变化中的可能作用。接种产生死亡率剂量细菌的动物,从大量腹腔渗出液的存在和循环血量的减少判断,显示出血管通透性的时间和剂量依赖性增加。同时,在循环血量减少发展之前,可从腹腔渗出液和脾脏中获得大量的血小板活化因子。(摘要截断于400字)